Expansion and Strengthening of Clinic-Based HIV Related Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR) | Apply Online

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is a continuation cooperative agreement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC). It focuses on expanding and strengthening clinic-based HIV-related services in Haiti under the President's Emergency Plan for AIDS Relief (PEPFAR).

Which agency is offering the opportunity?

The opportunity is offered by HHS-CDC (the Centers for Disease Control and Prevention, within the U.S. Department of Health and Human Services).

What is the funding mechanism: grant or cooperative agreement?

The opportunity is a cooperative agreement, not a standard grant. In cooperative agreements, CDC typically has substantial programmatic involvement during implementation, which can include technical guidance, oversight, and a more hands-on partnership approach.

What does "Continuation" mean for this opportunity?

The opportunity category is "Continuation," meaning it is intended to extend or continue work under an existing project or previously funded program rather than open a brand-new, fully competitive award for first-time applicants.

Is this opportunity likely open to new applicants?

Based on the continuation label and how these awards are commonly structured, eligibility may be limited to an existing implementer or a defined set of organizations already engaged in the CDC/PEPFAR portfolio in Haiti. The public summary indicates the applicant type as "Others" and notes that applicants should consult the "Additional Information on Eligibility" section in the full announcement for specifics.

What is the CFDA number and what does it indicate?

The opportunity is tied to CFDA 93.067, which corresponds to CDC's HIV prevention and related public health programming authority.

What is the main purpose of the award?

The implied purpose is to improve the reach, quality, and reliability of HIV services delivered through clinics in Haiti, consistent with PEPFAR priorities and clinic-based service delivery strengthening.

What kinds of activities might be supported under "clinic-based HIV-related services" in the PEPFAR context?

While the short notice does not list required components, clinic-based HIV services under PEPFAR commonly include HIV testing and counseling, linkage to care, initiation and maintenance of antiretroviral therapy (ART), retention and adherence support, prevention of mother-to-child transmission (PMTCT) within maternal and child health settings, clinical monitoring and laboratory support linkages (such as CD4 and viral load referral systems where applicable), management of opportunistic infections and co-infections (including tuberculosis), and systems strengthening (training, clinical mentoring, supply chain coordination for HIV commodities, data systems, and quality improvement).

What does "expansion and strengthening" typically mean in this context?

"Expansion and strengthening" typically means both scaling coverage (serving more patients and/or additional sites) and improving performance in existing sites. This often aligns with measurable service delivery outcomes such as increased testing yield, faster linkage to ART, improved retention at 6 and 12 months, and higher viral suppression.

What country or geographic area is the focus?

The work is focused on Haiti.

Is this opportunity part of PEPFAR?

Yes. The opportunity is explicitly described as being under the President's Emergency Plan for AIDS Relief (PEPFAR).

What is the funding opportunity number?

The Funding Opportunity Number is CDC RFA GH15-153002CONT16.

When was this opportunity posted?

The posting date listed is January 20, 2016.

What is the application deadline?

The closing date is listed as March 21, 2016. The record notes both an original and current closing date of March 21, 2016.

How many awards does CDC expect to make?

The announcement indicates an expectation of a single award (Expected Awards: 1).

Does "Expected Awards: 1" mean subawards are not allowed?

Not necessarily. The summary suggests one primary implementing organization may be funded, and that organization could potentially issue subawards to local partners, clinics, or NGOs as part of a broader service delivery network. Details would typically be addressed in the full announcement or project guidance.

Is there a stated maximum funding amount (award ceiling)?

The award ceiling is listed as 0 in the summary record, which commonly indicates that a maximum amount is not specified in that summary and would instead be provided in the full funding announcement or associated continuation instructions.

What funding activity category does this opportunity fall under?

It sits within the health funding activity category.

How involved is CDC expected to be during implementation?

Because this is a cooperative agreement, the intent is generally a closer partnership model with substantial CDC involvement, including technical guidance and oversight throughout implementation, rather than only periodic reporting typical of some standard grants.

Where should an applicant look to confirm eligibility details?

The summary explicitly notes that eligibility clarification is found in the "Additional Information on Eligibility" section of the full announcement.

What is the overall takeaway for potential applicants?

This is a CDC/PEPFAR continuation cooperative agreement intended to sustain and enhance clinic-based HIV service delivery in Haiti through a closely managed partnership model, likely aimed at an incumbent or otherwise specifically eligible implementer, with one anticipated award and a deadline of March 21, 2016.